SOD1 gene variants rs4817415, rs2070424, and rs1041740 and their association with breast cancer risk
M.P. Gallegos-Arreola, M.G. Márquez-Rosales, B.C. Gómez-Meda, G.M. Zúñiga-González, A.M. Puebla-Pérez, A.L. Zamora-Pérez, J.I. Delgado-Saucedo, L.E. Figuera División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, México. luisfiguera@yahoo.com
OBJECTIVE: The aim of this investigation was to determine the frequency and association of the variants rs4817415, rs2070424, and rs1041740 of the SOD1 gene in healthy women and breast cancer (BC) patients.
PATIENTS AND METHODS: Genomic DNA samples from 146 healthy women and 130 patients with BC were analyzed.
RESULTS: GG genotype (OR 2.54, 95% CI 1.31-4.91, p = 0.0073) and the G allele (OR 1.37, 95% CI 1.09-1.73, p = 0.007) of the rs2070424 variant and CC genotype (OR 1.67, 95% CI 1.04-0.2.70, p = 0.0444) and allele C (OR 1.58, 95% CI 1.09-2.29, p = 0.0183) of the rs1041740 variant of SOD1 gene were associated as risk factors for BC susceptibility relative to the control group. Study groups comparison of the stratification by menopausal status showed an association of susceptibility to BC risk with carriers of the GG genotype (OR 2.9, 95% CI 1.11-7.81, p = 0.042) of the rs2070424 variant and with the premenopausal status of the study group and the TT (OR 2.89, 95% CI 1.73-4.85, p = 0.001) genotype of the rs1041740 variant. Furthermore, differences were observed in the patients with BC who were carriers of the CC genotype of the rs4817415 variant with elevated Ki-67 (≥ 20%) and who presented lymph node metastasis and stage III-IV BC (p<0.05). Two common haplotypes were identified in the study groups: CAC (protective factor), and CGC (risk factor) (p<0.05).
CONCLUSIONS: The rs2070424 and rs1041740 variants of the SOD1 gene and the CGC haplotype were associated as risk susceptibility factors of BC in this sample analyzed.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M.P. Gallegos-Arreola, M.G. Márquez-Rosales, B.C. Gómez-Meda, G.M. Zúñiga-González, A.M. Puebla-Pérez, A.L. Zamora-Pérez, J.I. Delgado-Saucedo, L.E. Figuera
SOD1 gene variants rs4817415, rs2070424, and rs1041740 and their association with breast cancer risk
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 7
Pages: 3088-3095
DOI: 10.26355/eurrev_202304_31943